@ARTICLE{
author={Trukhin Dmytro,Poddubskaya Elena,Andric Zoran G,Bondarenko Igor N,Shevnia Serhii,Zaric Bojan,Bellala Ravishankar,Charoentum Chaiyut,Perez Luis,Bullo Felicitas,Garcia Fernanda},
year={2021},
title={Bevacizumab biosimilar (MB02) and reference bevacizumab in patients with stage IIIB/IV non-squamous non-small cell lung cancer (NSCLC) (STELLA study): Multiple Imputation analysis.},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={39},
number={15},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Millan Susana,Trukhin Dmytro,Kolesnik Oleksii,Poddubskaya Elena,Andric Zoran G,Bondarenko Igor N,Shevnia Serhii,Bullo Felicitas,Sarnago Cristina},
year={2020},
title={Bevacizumab biosimilar and reference bevacizumab in subjects with stage IIIB/IV no squamous non-small cell lung cancer (NSCLC) (STELLA study): Results for the primary endpoint in a confirmatory, double-blind, randomized, controlled study.},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={38},
number={15},
pages={-},
document_type={Meeting Abstract},
}